Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
283 GBX | -2.41% | -4.07% | 0.00% |
07/06 | Hutchmed (China) begins trial of menin inhibitor HMPL-506 | AN |
07/06 | Hutchmed Begins Phase 1 Trial of Potential Treatment for Acute Myeloid Leukemia | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 307.37Cr | |
+45.82% | 77TCr | |
-6.16% | 35TCr | |
+19.86% | 33TCr | |
+9.32% | 30TCr | |
+18.45% | 25TCr | |
-0.78% | 22TCr | |
+11.88% | 22TCr | |
+5.90% | 16TCr | |
-0.73% | 16TCr |
- Stock Market
- Equities
- HCM Stock
- News HUTCHMED (China) Limited
- HUTCHMED China : Doses First Patient in Study of Potential Drug for Breast, Endometrial Cancers